Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...
Patients treated in an outpatient setting who later required admission spent an average of 12.1 days in the hospital, ...
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...
The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.
"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...
The MarketWatch News Department was not involved in the creation of this content. MiniPRO(TM) - Independent Control of up to 24 Cultures for Scalable, Closed-System Cell Therapy Development CAMARILLO, ...
Lumacyte CEO on how real-time insight is driving down manufacturing failures and opening doors for more patients.
Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...
The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback